In the present study, we found that increased expression of CPT1C is significantly linked to poor relapse-free survival (RFS) in CRC (HR 2.1,P=0.0006), while no statistical significance is found for CPT1A and CPT1B. This evidence concerns the gene CPT1C and colorectal carcinoma.